| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.77 | 2e-08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.59 | 2e-05 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.55 | 0.0002 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.52 | 0.0008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.54 | 0.001 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.53 | 0.001 |